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Abstract
Background: In contrast to colorectal surgery, enhanced recovery pathways (ERPs) have not yet
become standard practice after major upper abdominal surgery. The aim of this study was to assess
the feasibility and outcomes after implementation of an ERP after liver a resection.
Methods: Patients who underwent a liver resection in two consecutive 6-month periods before (July–
December 2013) and after (January–June 2014) implementation of an ERP were included in a prospec-
tive study. Patients who underwent live donation, ALPPS (associating liver partition with portal vein
ligation for staged hepatectomy) or concomitant procedures were excluded. Peri-operative outcomes
were compared between groups, and multivariate analysis of factors influencing the length of hospital
stay (LOS) was performed.
Results: Two hundred and eleven patients (93 pre-ERP and 91 post-ERP patients) underwent a liver
resection during the study period. There was no significant difference in the median LOS (P = 0.907)
and 30-day readmission rates (P = 0.645) between the groups. Severe (Clavien grade III–V) complica-
tions were reduced in ERP patients (13.9% versus 4.3%; P = 0.039). On multivariate analysis, an
increased age (< 0.001), open resection (< 0.001) and complications (< 0.001) were associated with an
increased LOS.
Conclusion: Enhanced recovery after a liver resection appears to be safe, feasible and may reduce
severe complications. However, the LOS was significantly influenced by patient age, open surgery and
post-operative complications, but not by an ERP.
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Introduction
A liver resection is a potentially curative treatment for both pri-
mary and secondary liver tumours1 in selected patients with low
rates of peri-operative mortality (1–3%).2 However, post-opera-
tive complications, particularly after a major resection, are com-
mon, and develop in up to 30% of patients.3,4 Enhanced recovery
pathways after surgery (ERP) have become well established in
many colorectal units, and have been associated with an earlier
return to normal function, a reduced post-operative length of
stay and reduced complications.5–9 Several ERP interventions,
such as opioid-sparing analgesia and early mobilization, could be
considered as good clinical practice.10 Other ERP elements, some
of which are evidence-based,11–13 have been incorporated into
surgical care, outside of ERP pathways, in an incremental, but
often uncontrolled manner. Consensus guidelines on ERP have
been published for a range of major abdominal procedures,
including a gastrectomy14 and pancreaticoduodenectomy;15 how-
ever, adoption of ERP pathways outside of colorectal units con-
tinues to evolve, and this approach has not yet become fully
established into routine clinical practice.
There is currently limited evidence to support a role for
ERP after a liver resection.16,17 Apart from one randomized
trial,18 several retrospective series and other randomized trials
have failed to show any significant reduction in post-operative
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complications after implementation of an ERP pathway after a
liver resection.19–25
According to a systematic review by Coolsen et al.,26 ERP
may reduce the length of hospital stay after a liver resection.
However, the median length of stay in the control groups in
some studies was as long as 11 days,25 and there was no differ-
ence in length of hospital stay (LOS) in two out of three ran-
domized trials.20,21,27 The principal aim of this study was to
evaluate the effect of systematic implementation of an enhanced
recovery pathway after a liver resection in a single, high-volume
liver unit, and the secondary aim was to investigate the factors
that influence post-operative LOS after a liver resection.
Patients and methods
Peri-operative and outcome data for all patients were routinely
entered into a prospectively maintained database. An ERP was
systematically introduced on 1st January 2014 for all patients
undergoing a liver resection, with the exception of complex
procedures, specifically live liver donation, ALPPS (associating
liver partition with portal vein ligation for staged hepatec-
tomy)28 or concomitant colonic, vascular or a bile duct resec-
tion. Short-term outcomes and LOS were retrospectively
compared with a consecutive series of liver resections per-
formed in the 6-month period before the implementation of
ERP. All medical and nursing staff involved in caring for
patients undergoing liver resection were educated about the
ERP prior to its implementation.
Peri-operative care: all patients
All patients who underwent a liver resection were discussed at a
multidisciplinary team meeting prior to surgery. A standardized
anaesthetic regimen with fentanyl and propofol was used for
induction and then atracurium or rocuronium dependent on cli-
nician preference. All patients received thromboprophylaxis
using thromboembolic deterrent stockings, intermittent pneu-
matic calf compression during surgery and daily subcutaneous
low-molecular-weight heparin injections post-operatively. Post-
operative analgesia was achieved via a thoracic epidural infusion
of levobupivacaine (0.125%) and fentanyl (2–4 lg/ml) in the
majority of patients. Depending on age and co-morbidities, plain
levobupivacaine (0.125%) alone was used according to individ-
ual anaesthetist preference. Patient-controlled analgesia pumps
delivering boluses of intravenous morphine were used for a
minority of patients who had declined an epidural, or in whom
an epidural was either not possible or non-functioning. Patients
who underwent laparoscopic minor liver resections received a
bolus injection of diamorphine (300 lg) with bupivacaine
(0.25%) into the spinal canal after induction of anaesthesia,
rather than an epidural, according to individual anaesthetist
preference. There was no difference in operative approach or a
surgical technique between the two groups: patients underwent
either a laparoscopic or open liver resection, according to the
surgeon’s preference. The type of resection (major or minor)
was determined by the size and location of lesion(s), and a
parenchymal transection was performed using a combination of
CUSA (Cavitron Ultrasonic Surgical Aspirator; Integra, And-
over, UK) and an ultrasonic dissector (Thunderbeat, Olympus,
UK). A parenchymal transection was routinely carried out with a
low central venous pressure (0–5 cm water), anaesthetic-induced
systemic hypotension and selective hepatic inflow occlusion.
Intra-abdominal drains were inserted at the time of surgery at the
discretion of the operating surgeon. Post-operatively, all patients
were transferred to a high-dependency unit for invasive arterial
and central venous pressure monitoring, and subsequently
stepped down to an acute surgical ward on or after the first post-
operative day. Post-operative hypotension was managed either by
intravenous fluid boluses or a vasoconstrictor (noradrenaline)
depending on the patient’s haemodynamic status, central venous
pressure and the underlying cause. All patients were allowed free
oral fluids and diet as tolerated and were encouraged to mobilize
with physiotherapists. Intravenous fluids were discontinued when
oral intake was deemed satisfactory.
A summary of the differences between pre- and post-ERP
groups is presented in Table 1.
Peri-operative care: pre-ERP patients
Post-operatively, surgical drains were removed at the discretion
of the attending consultant surgeon, usually on or after the
fourth post-operative day. Epidural and urinary catheters were
also removed on the fourth post-operative day, and patients
received regular oral Paracetamol 1 g QDS and Tramadol
50 mg TDS, and Oramorph 5–10 ml for breakthrough pain as
required. Patients were encouraged to mobilize, and in uncom-
plicated cases were typically discharged 24–48 h after removal
of the epidural, but there were no defined discharge criteria.
Peri-operative care: ERP patients
Post-operatively, ERP patients were managed according to a
defined pathway, which included defined daily mobilization
targets and discharge criteria: patient clinically well and tem-
perature less than 37.5 °C; pain controlled on oral analgesia;
tolerating oral fluids and diet; serum bilirubin <50 lmol/l or
falling); and independently mobile. Although several ERP ele-
ments (Table 1) were already in routine practice in pre-ERP
patients, the following interventions were modified/added for
ERP patients: (i) regular sublingual prochlorperazine; (ii) regu-
lar oral codeine 30–60 mg QDS (instead of tramadol); (iii)
standardized early drain removal (if no evidence of bile leak)
and early removal of urinary and epidural catheters.
Data collection and analysis
Data were collected prospectively and included patient demo-
graphics, type of liver resection and post-operative outcomes.
Post-operative complications were reported according to the
Clavien–Dindo classification.29 Outcomes were compared
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between patients treated during two consecutive 6-month peri-
ods (July–December 2013 and January–June 2014), before and
after introduction of the enhanced recovery pathway.
Patient characteristics and outcomes were initially compared
between the pre-ERP and ERP groups, using Fisher’s exact test
for categorical variables, and either Mann–Whitney tests or
t-tests for continuous variables, depending on whether the
normality assumption was met. The median lengths of stay
were then compared across the same factors, using Mann–
Whitney or Kruskal–Wallis tests for categorical factors, and
Spearman’s correlation coefficients for continuous ones. The
factors from the univariate analysis of length of stay were then
entered into a multivariable general linear model. The lengths
of stay were log10-transformed, to reduce the level of skew in
the distribution, before being used as the dependent variable in
the model. The resulting coefficients were then anti-logged and
converted to percentage differences for ease of interpretation.
All analyses were performed using IBM SPSS Statistics 22
(IBM Corp., Armonk, NY, USA), with P < 0.05 deemed to be
indicative of statistical significance. The primary outcome was
post-operative LOS, and secondary outcomes were readmission
rates and morbidity (medical/surgical complications).
Results
Overall, 211 patients underwent a liver resection during the
study period. Of these, 27 (13%) patients were excluded (con-
comitant procedures 15; live liver donor 7; ALPPS 3; post-
operative death <72 h 2). There was no significant difference
in patient demographics or type of liver resection between
groups (Table 2). Post-operative outcomes are shown in
Table 3. Factors associated with a prolonged hospital stay on
univariate analysis and multivariate analyses are shown in
Tables 4 and 5, respectively.
Discussion
There is good evidence from colorectal surgery that imple-
mentation of a multimodal enhanced recovery pathway leads
Table 1 Comparison of ERP interventions before and after
implementation of the Enhanced Recovery Pathway
ERP elements16 Pre-ERP Post-ERP
Pre-operative
Pre-operative counselling ✗ U
Minimal pre-op fasting + carbohydrate
loading
✗ U
No anxiolytic premedication U U
Peri-operative
Thoracic epidural analgesia* U U
Prevention of hypothermia U U
CVP monitoring (CVP <5 mmHg) U U
No routine drainage of peritoneal cavity** ✗ U
No standard nasogastric drainage U U
Start intake of water and free fluids U U
Early mobilization ✗ U
Post-operative nausea and vomiting
prophylaxis
✗ U
Antithrombotic prophylaxis U U
Antibiotic prophylaxis U U
Post-operative
Daily review of discharge criteria ✗ U
Ileus prevention ✗ ✗
Free fluids/normal diet POD1 U U
Intravenous fluids discontinued POD1 ✗ U
Oral analgesia POD1 ✗ U
Normal diet POD2 U U
Removal of urinary catheter POD2 ✗ U
Stop epidural/intravenous
analgesis POD3
✗ U
Full mobilization POD3 ✗ U
*Spinal injection of local anaesthetic/diamorphine for laparoscopic liver
resection.
**Drains removed on POD2 in ERP patients if no evidence of bile leak.
CVP, central venous pressure; POD, post-operative day.
Table 2 Patient demographics
Pre-ERP
(N = 93)
ERP
(N = 91)
P-value
Age (years) 63.4 (10.8) 65.2 (12.3) 0.297
BMI 28.1 (5.1) 27.6 (5.2) 0.586
Gender (%)
Male 58 (62.3) 58 (63.7) 0.879
Female 35 (37.6) 33 (36.2)
Type of resection (%)
Hemihepatectomy 36 (38.7) 32 (35.1) 0.386
Extended 13 (13.9) 8 (8.7)
Non-anatomical/segmental 44 (47.3) 51 (56.0)
Open or laparoscopic approach (%)
Open 81 (87.0) 70 (76.9) 0.085
Laparoscopic 12 (12.9) 21 (23.0)
Indication for resection (%)
Colorectal
metastases
61 (65.5) 60 (65.9) 1
Hepatocellular
carcinoma
17 (18.2) 4 (4.3) 0.004*
Other 15 (16.1) 27 (29.6) 0.035*
Presence of background
cirrhosis (%)
4 (4.3) 0 0.121
Categorical data reported as: ‘N (%)’, with P-values from Fisher’s
exact tests. Continuous data reported as ‘mean (SD)’, with P-values
from t-tests. *Significant at P < 0.05.
ERP, enhanced recovery pathway.
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to a faster post-operative recovery, shorter hospital stay and
reduced complications.30 Other surgical specialities, including
upper gastrointestinal and hepatobiliary surgery, have also
adopted ERP principles, but it is not clear whether such an
approach is beneficial in patients undergoing major upper
abdominal surgery. Data from several case-controlled studies
and small randomized trials have shown that the LOS may be
reduced in patients managed in an ERP pathway after a liver
resection.19,21,22,25,27 This study evaluated the effect of system-
atic implementation of an enhanced recovery pathway in all
patients undergoing a liver resection in a single centre, but
found no significant difference in median LOS compared with
patients treated before the pathway. There are several potential
explanations for the discrepancy between data from this study
and published series. Although the lack of any difference may
be due to a type II statistical error, this is unlikely as as there
are more patients included in this series than those published
in the literature (Table 6). The median LOS of pre-ERP
patients in this study (6 days) was shorter than the control
groups in several other studies,19,23,25,27 and this may explain
the lack of any difference observed in ERP patients in the cur-
rent series. It is not clear what the relative impact is of each
ERP intervention on the length of stay, but it is likely that the
combination of several interventions is relevant. Ten out of 22
ERP interventions were already in routine practice16 (Table 1),
and this may explain why the median LOS was only 6 days in
pre-ERP patients. In a recently published randomized trial of
91 patients undergoing a liver resection, a median LOS in
patients treated within an ERP was only 4 days.27
In this study, there were fewer medical complications in
ERP patients and readmission rates were low in both groups.27
Whether it is feasible to achieve a sustained reduction in length
of stay after an open liver resection in routine practice, without
compromising quality of care or readmission rates, is unclear,
and importantly these results have not been reproduced. Fac-
tors such as patient age, open surgery and post-operative com-
plications appear to be more important than ERP principles in
determining the LOS after a liver resection.
Compliance with ERP protocols is variable and is also likely
to influence outcomes, particularly when a pathway is newly
introduced into a department. In a departmental audit, it was
subsequently found that daily mobilization targets were met on
the first, second and third post-operative days in 25%, 53%
and 68% of patients, respectively. Reasons for non-compliance
in these patients included epidural-related hypotension or diz-
ziness, pain and patient refusal. These factors were particularly
prevalent in the first 24–48 h post-operatively and may have
been relevant in delaying patient recovery. Education and
empowerment of patients and staff is a key aspect of a success-
ful enhanced recovery pathway, and relies upon effective team-
working, communication and commitment from all staff
involved in the patient’s pathway, from their pre-operative
assessment through to successful discharge.
It is unclear if ERP pathways reduce morbidity after a liver
resection. Complications were reduced in ERP patients in two
randomized trials performed in the UK27 and China,18 but
other studies have failed to show any difference. In this study,
the overall incidence of complications was similar before and
after implementation of the ERP (Table 3). However, severe
complications (Clavien grade III–V) were less common in the
ERP group. This difference appears to be due to fewer intra-
abdominal collections in ERP patients (0% versus 6.4%; P =
0.03 Fisher’s exact test). This finding could potentially be
explained by a policy of early drain removal [postoperative day
2 (POD2)] in ERP patients. Based on data from two random-
ized trials in the 1990s, routine abdominal drainage after a
liver resection was associated with infected collections and did
not reduce the morbidity or mortality.31,32 In a recent meta-
analysis of five trials including 465 patients, Gurusamy et al.33
also concluded that routine abdominal drainage was unneces-
sary. Despite this evidence, many surgeons routinely drain the
abdominal cavity after a liver resection primarily to facilitate
earlier diagnosis and/or treatment of a post-operative bile leak.
A pragmatic approach of early drain removal after excluding a
Table 3 Post-operative outcomes
Pre-ERP
(N = 93)
ERP
(N = 91)
P-value
Complications (%)
All 32 (34.4) 30 (32.9) 0.876
Grade III–V 13 (13.9) 4 (4.3) 0.039*
Medical 16 (17.2) 13 (14.2) 0.687
Surgical 16 (17.2) 17 (18.6) 0.848
Grade III–V complications (%)
Bile leak 1 (1.0) 3 (3.2) 0.302
Intra-abdominal collection 6 (6.4) 0 (0) 0.015*
Respiratory failure/pleural
effusion
3 (3.2) 0 (0) 0.127
Haematoma 2 (2.1) 1 (1.0) 0.508
Adhesional bowel obstruction 1 (1.0) 0 (0) 0.505
Surgical complications (%)
Bile leak 1 (1.0) 4 (4.3) 0.201
Liver failure 1 (1.0) 4 (4.3) 0.209
Intra-abdominal collection 10 (10.7) 5 (5.4) 0.282
Wound infection 2 (2.1) 4 (4.3) 0.442
90-day mortality (%) 1 (1.0) 1 (1.0) 1.000
Median time to discharge
criteria in days#
5 (4–7) 5 (4–7) 0.893
Median length of hospital
stay in days#
6 (5–8) 6 (5–7) 0.907
30-day hospital readmission (%) 12 (12.9) 9 (9.8) 0.645
Categorical data reported as: ‘N (%)’, with P-values from Fisher’s
exact tests #’median (quartiles)’, with P-value from a Mann-Whitney
test. *Significant at P < 0.05.
ERP, enhanced recovery pathway.
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bile leak was used in our protocol, and this may have contrib-
uted to fewer intra-abdominal collections.
This study has several limitations. Although this study was
not conducted in a randomized fashion, data were collected
prospectively, and the principal aim was to assess the impact
of implementing an enhanced recovery pathway into routine
clinical practice. Patients undergoing complex procedures or
live liver donation were excluded from this study. It was felt
that the high probability of post-operative complications in
patients undergoing a complex liver resection was not condu-
cive to a faster recovery and earlier discharge within an
enhanced recovery pathway. However, some of the ERP princi-
ples were applied to this subgroup outside of the formal path-
way. Similarly, the authors felt that live liver donors
represented a unique patient population that were not appro-
priate to be included in the first phase of implementation of
an enhanced recovery pathway.
Table 4 Univariate analysis of factors influencing the post-
operative length of hospital stay
Length of stay P-value
Age (years) 0.168 0.023*
BMI 0.091 0.221
Sex
Male 5 (4–7) 0.092
Female 6 (5–8)
ERP
No 6 (5–8) 0.907
Yes 6 (5–7)
Type of resection
Hemihepatectomy 6 (5–8) 0.002*
Extended 7 (6–11)
NAR/Segmental 5 (4–7)
Open or laparoscopic approach
Lap 4 (3–6) <0.001*
Open 6 (5–8)
Complications
Any Grade 3+
No 6 (5–7) <0.001*
Yes 10 (8–28)
Medical
No 5 (4–7) <0.001*
Yes 8 (6–12)
Surgical
No 5 (4–7) <0.001*
Yes 10 (7–15)
Bile leak
No 6 (5–7) 0.005*
Yes 10 (10–13)
Liver failure
No 6 (5–7) 0.001*
Yes 15 (8–20)
Percutaneous drain
No 6 (5–7) 0.463
Yes 7 (6–8)
Wound infection
No 6 (5–7) 0.286
Yes 7 (5–13)
Intra-abdominal collection
No 6 (5–7) <0.001*
Yes 9 (7–13)
Hospital readmission (Within 30 days)
No 6 (5–7) 0.976
Yes 6 (4–7)
Categorical factors reported as: ‘median (quartiles)’, with P-values from
Mann–Whitney/Kruskal–Wallis tests, as applicable. Continuous factors
reported as Spearman’s correlation coefficients. *Significant at P <
0.05.
BMI, body mass index; ERP, enhanced recovery pathway.
Table 5 Multivariable analyses of factors influencing the length of
post-operative hospital stay
Coefficient (95% CI) P-value
Age (Decades) 8.2% (2.5, 14.3) 0.005*
BMI 1.1% (0.1, 2.3) 0.083
Gender 0.006*
Female 20.3% (5.5, 37.0) 0.006*
Male – –
ERP 0.151
Yes 9.6% (3.3, 24.3) 0.151
No – –
Type of resection 0.058
Hemi 11.8% (2.7, 28.4) 0.114
Extended 26.4% (2.8, 55.5) 0.027
NAR/Segmental – –
Surgery Type 2 <0.001*
Lap –28.4% (39.3, 15.5) <0.001*
Open – –
Complication - Any Grade 3+ <0.001*
Yes 82.4% (40.0, 137.5) <0.001*
No – –
Complication - Medical <0.001*
Yes 49.9% (26.7, 77.4) <0.001*
No – –
Complication - Surgical <0.001*
Yes 40.6% (14.7, 72.5) <0.001*
No – –
Results from a multivariable general linear model, with log10[Length of
Stay] as the dependent variable. Coefficients from the model were
anti-logged, and converted to percentage differences in length of stay.
BMI, body mass index; ERP, enhanced recovery pathway. *Significant
at P < 0.05.
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In conclusion, this study provides further evidence that
enhanced recovery principles can be safely applied to patients
undergoing a liver resection, and may even reduce severe com-
plications. In the present study, the enhanced recovery pathway
was not associated with a significant reduction in LOS.
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